(MedPage Today) — The treatment of relapsed/refractory multiple myeloma dramatically changed in recent years with the emergence of therapies such as chimeric antigen receptor (CAR) T-cell products and antibody-drug conjugates. While these therapies…
Source link : https://www.medpagetoday.com/spotlight/multiple-myeloma/118326
Author :
Publish date : 2025-11-05 20:32:00
Copyright for syndicated content belongs to the linked Source.
